Technology Development Resources
Diagnostics Research and Development Resources
Human Specimen Resources
Ethical, Legal and Social Implications of Biobanking in Cancer Research
Recommendations, Publications and Multimedia
Last Updated: 03/05/18
Scientific Publications
Publications published in peer-reviewed journals from CDP and its staff can be viewed here.
Biobanking and Biospecimen Research
| Title | Year of Publication |
|---|---|
Broad Consent for Research on Biospecimens: The Views of Actual Donors at Four U.S. Medical Centers. 
Warner TD, Weil CJ, Andry C, Degenholtz HB, Parker L, Carithers LJ, Feige M, Wendler D, Pentz RD. J Empir Res Hum Res Ethics. 2018 Jan 1:1556264617751204. doi: 10.1177/1556264617751204. [Epub ahead of print] PMID: 29390947 |
2018 |
| Understanding preanalytical variables and their effects on clinical biomarkers of oncology and immunotherapy.
L Agrawal et al. Seminars in Cancer Biol. (2017). |
2017 |
Diagnostics Evaluation
| Title | Year of Publication |
|---|---|
| Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference. VN Giri et al. J Clin Oncol. (2017). | 2017 |
| Evaluation of a Methodology for Automated Cell Counting for Streak Mode Imaging Flow Cytometry.
M Ossandon et al. Journal of Analytical & Bioanalytical Techniques. (2017). |
2017 |
| A Non-Gas-Based Cryotherapy System for the Treatment of Cervical Intraepithelial Neoplasia: A Mixed-Methods Approach for Initial Development and Testing. M Cremer et al. Glob Health Sci Pract. (2017) | 2017 |
| Non-alcoholic Steatofibrosis Independently Predicts Mortality in Non-alcoholic Fatty Liver Disease.
Z Younoszai et al. Hepatology Communications. (2017). |
2017 |
| Characterization of the HLA-DRB1*07:01 biomarker for lapatinib-induced liver toxicity during treatment of early-stage breast cancer patients with lapatinib in combination with trastuzumab and/or taxanes. CF Spraggs et al. Pharmacogenomics J. (2017). | 2017 |
| Analytical Validation of the Next-Generation Sequencing Assay for a Nationwide Signal-Finding Clinical Trial (NCI-MATCH, EAY131).
Lih C-J, Harrington RD, Sims DJ, Harper KN, Bouk CH, Datta V, Yau J, Singh RR, Routbort MJ, Luthra R, Patel KP, Mantha GS, Krishnamurthy S, Ronski K, Walther Z, Finberg KE, Canosa S, Robinson H, Raymond A, Le LP, McShane LM, Polley EC, Conley BA, Doroshow JH, Iafrate AJ, Sklar JL, Hamilton SR, Williams PM. J. Mol. Diagn. (2017) 19:313-327. |
2017 |
| Development and validation of a Luminex assay for detection of a predictive biomarker for ROSTVAC-VF therapy. Lucas JL, Tacheny EA, Ferris A, Galusha M, Srivastava AK, Ganguly A, Williams PM, Sachs MC, Thurin M, Tricoli JV, Ricker W, Gildersleeve JC. PLoS One. (August 2017) 2(8):e0182739. PMID: 28771597 | 2017 |
| Validation of Immunohistochemical Assays for Integral Biomarkers in the NCI-MATCH EAY131 Clinical Trial.
Khoury JD, Wang W-L, Prieto VG, Medeiros LJ, Kalhor N, Hameed M, Broaddus R, Hamilton SR. Clin. Cancer Res. (August 2017) DOI: 10.1158/1078-0432.CCR-17-1597 |
2017 |
| Immunotherapy biomarkers 2016: overcoming the barriers. Gulley JL, Berzofsky JA, Butler MO, Cesano A, Fox BA, Gnjatic S, Janetzki S, Kalavar S, Karanikas V, Khleif SN, Kirsch I, Lee PP, Maccalli C, Maecker H, Schlom J, Seliger B, Siebert J, Stroncek DF, Thurin M, Yuan J, Butterfield LH. J Immunother Cancer. 2(March 2017) 5(1):29. doi: 10.1186/s40425-017-0225-6. | 2017 |
| Nanotechnology Platforms and Physiological Challenges for Cancer Therapeutics. Kim, KY. Nanomedicine's Most Cited - Volume 1: Nanomedicine in Cancer, pp. 1-15, Balogh, Lajos P. (ed.). Singapore: Pan Stanford Publishing Pte. Ltd., 2017. ISBN: 9789814745802 [invited book chapter] | 2017 |
| Clinical Utility of Epstein-Barr Virus DNA Testing in the Management of Nasopharyngeal Carcinoma Patients. Kim KY, Le QT, Yom SS, Ng RHW, Chan KCA, Bratman SV, Welch JJ, Divi RL, Petryshyn RA, Conley BA. International Journal of Radiation Oncology Biology Physics (August 2017) 98(5):996-1001. | 2017 |
Diagnostic Biomarkers and Technology
| Title | Year of Publication |
|---|---|
| A mutational comparison of adult and adolescent and young adult (AYA) colon cancer. JV Tricoli et al. Cancer. (2018). | 2018 |
| A computational streak mode cytometry biosensor for rare cell analysis. M Ossandon et al. Analyst. (2017). | 2017 |
| Streak Imaging Flow Cytometer for Rare Cell Analysis. J Balsam et al. Methods Mol Biol. (2017) | 2017 |
| The Role of Affordable, Point-of-Care Technologies for Cancer Care in Low- and Middle-Income Countries: A Review & Commentary.
K Haney et al. IEEE Transl Engineering in Health and Med. (2017). |
2017 |
| India-U.S. Dialogue on Traditional Medicine – Towards Collaborative Research and Generation of an Evidence Base.
JD White et al. J Global Oncology. (2017). |
2017 |
| Predictive Markers and Driver Genes from Treatment Trials: Potential Utility for Early Diagnosis.
BS Sorg et al. Biomarkers in Cancer Screening and Early Detection. Srivastava S., editor. Wiley-Blackwell (2017) Chapter 19, p. 231-245. |
2017 |
| Biliary Adenofibroma of Liver: Morphology, Tumor Genetics, and Outcomes in 6 Cases. T Arnason et al. Am J Surg Pathol. (2017). | 2017 |
| Decoding NADPH oxidase 4 expression in human tumors. JL Meitzler et al. Redox Biol. (2017). | 2017 |
| The Yale Fitness Intervention Trial in female cancer survivors: Cardiovascular and physiological outcomes. MT Knobf et al. Heart Lung. 2017 | 2017 |
| The Biology of AYA Cancers. JV Tricoli. Cancer in Adolescents and Young Adults. Second edition, Bleyer R, Barr R, Ries L, Whelan J, Ferrari A (eds.), Springer-Verlag (2017). | 2017 |
| Pediatric oncology enters the era of precision medicine. SL Seibel et al. Current Problems in Cancer. (2017). | 2017 |
| Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2–Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial.
A Sonnenblick et al. J. Clin. Oncol. (2017). |
2017 |
| The Challenge for Development of Valuable Immunooncology Biomarkers. JM Mehnert et al. Clin Cancer Res. (2017). | 2017 |
| Steps forward for cancer precision medicine. R Salgado et al. Nat Rev Drug Discov. (2017). | 2017 |
| Societal challenges of precision medicine: Bringing order to chaos. R Salgado et al. Eur J Cancer. (2017). | 2017 |
| Decoding NADPH oxidase 4 expression in human tumors.
Metzler JL, Maklouf HR, Antony S, Wu Y, Butcher D, Jiang G, Juhasz A, Lu J, Dahan I, Jansun-Dürr P, Pircher H, Shah AM, Roy K, Doroshow JH. Redox Biology 13, pp 182-195 (October 2017). doi: 10.1016/j.redox.2017.05.016 |
2017 |
| NADPH oxidase 5 (NOX5)-induced reactive oxygen signaling modulates normoxic HIF-1α and p27Kip1 expression in malignant melanoma and other human tumors.
Antony S, Jiang G, We Y, Meitzler J, Makhlouf HR, Haines DC, Butcher D, Hoon SD, Ji J, Zhang Y, Juhasz A, Lu J, Liu H, Dahan I, Konate M, Roy KK, Doroshow JH. Molecular Carcinogenesis (August 2017) doi: 10.1002/mc.22708 |
2017 |
| Comprehensive and integrative genomic characterization of hepatocellular carcinoma.
The Cancer Genome Atlas Research Network. Cell 169, pp. 1327-1341 (June 2017) doi: 10.1016/j.cell.2017.05.046 |
2017 |
| Current State of PCR-Based Epstein-Barr Virus DNA Testing for Nasopharyngeal Cancer. Kim KY, Le Q-T, Yom SS, Ng RHW, Chan KCA, Bratman SV, Welch JJ, Divi RL, Petryshyn RA, Conley BA. JNCI J Natl Cancer Inst (2017) 109(4): djx007.10.1016/j.ijrobp.2017.03.018. | 2017 |